Transpalpebral Microcurrent Stimulation for the Improvement... | Clinical Trial | StuddyBuddy@endsection Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05703867

Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

Conditions: Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration

Sex: All
Ages: 50 Years – N/A
Phase: PHASE1, PHASE2
Enrollment: 404
Sponsor: Jarding, John, OD

Summary

The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration.Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.

Eligibility Criteria

Inclusion Criteria:Adults aged at least 50 years with dry AMD in at least one eyeExclusion Criteria:Eye diseases other than dry AMDImplanted electrical devicesSeizure disorders

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05703867). StuddyBuddy aggregates publicly available trial information.